Co-solvents as stabilizing agents during heterologous overexpression in Escherichia coli - application to chlamydial penicillin-binding protein 6

PLoS One. 2015 Apr 7;10(4):e0122110. doi: 10.1371/journal.pone.0122110. eCollection 2015.

Abstract

Heterologous overexpression of foreign proteins in Escherichia coli often leads to insoluble aggregates of misfolded inactive proteins, so-called inclusion bodies. To solve this problem use of chaperones or in vitro refolding procedures are the means of choice. These methods are time consuming and cost intensive, due to additional purification steps to get rid of the chaperons or the process of refolding itself. We describe an easy to use lab-scale method to avoid formation of inclusion bodies. The method systematically combines use of co-solvents, usually applied for in vitro stabilization of biologicals in biopharmaceutical formulation, and periplasmic expression and can be completed in one week using standard equipment in any life science laboratory. Demonstrating the unique power of our method, we overproduced and purified for the first time an active chlamydial penicillin-binding protein, demonstrated its function as penicillin sensitive DD-carboxypeptidase and took a major leap towards understanding the "chlamydial anomaly."

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Proteins / chemistry
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Betaine / chemistry
  • Catalytic Domain
  • Chlamydia / metabolism*
  • Cloning, Molecular
  • Escherichia coli / metabolism*
  • Mutagenesis, Site-Directed
  • Penicillin-Binding Proteins / chemistry
  • Penicillin-Binding Proteins / genetics
  • Penicillin-Binding Proteins / metabolism*
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / isolation & purification
  • Solvents / chemistry*

Substances

  • Bacterial Proteins
  • Penicillin-Binding Proteins
  • Recombinant Proteins
  • Solvents
  • Betaine

Grants and funding

CO and HB received a PhD fellowship from the Jürgen Manchot foundation. AG and SDB obtained a fellowship from the German Academic Exchange Service (DAAD) and from the NRW International Graduate Research School Biotech-Pharma, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.